Rethinking hair loss treatment
In this episode of Denatured, you'll be hearing from Daniel Gil, CEO of Pelage Pharmaceuticals and Francisco Ramírez-Valle, senior vice president of immunology discovery at Eli Lilly. We dive into the long-overlooked hair loss space, exploring why true innovation has lagged, how a regenerative approach aims to reactivate dormant follicles and what early proof-of-concept means for patients.
Host
Jennifer C. Smith-Parker, Director of Insights, BioSpace
Guests
Daniel Gil, CEO, Pelage Pharmaceuticals
Francisco Ramírez-Valle, Senior Vice President, Immunology Discovery, Eli Lilly
Disclaimer: The…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.